479 related articles for article (PubMed ID: 18245396)
1. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
[TBL] [Abstract][Full Text] [Related]
2. Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines.
Pichichero ME; Gentile A; Giglio N; Alonso MM; Fernandez Mentaberri MV; Zareba G; Clarkson T; Gotelli C; Gotelli M; Yan L; Treanor J
J Pediatr; 2009 Oct; 155(4):495-9. PubMed ID: 19560158
[TBL] [Abstract][Full Text] [Related]
3. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Rooney JP
Pediatrics; 2008 Oct; 122(4):902; author reply 902-3. PubMed ID: 18829819
[No Abstract] [Full Text] [Related]
4. Toxicokinetics of mercury after long-term repeated exposure to thimerosal-containing vaccine.
Barregard L; Rekić D; Horvat M; Elmberg L; Lundh T; Zachrisson O
Toxicol Sci; 2011 Apr; 120(2):499-506. PubMed ID: 21252391
[TBL] [Abstract][Full Text] [Related]
5. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.
Pichichero ME; Cernichiari E; Lopreiato J; Treanor J
Lancet; 2002 Nov; 360(9347):1737-41. PubMed ID: 12480426
[TBL] [Abstract][Full Text] [Related]
6. [Mercury in vaccines].
Hessel L
Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
[TBL] [Abstract][Full Text] [Related]
7. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Parker SK; Schwartz B; Todd J; Pickering LK
Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants.
Magos L
J Appl Toxicol; 2003; 23(4):263-9. PubMed ID: 12884410
[TBL] [Abstract][Full Text] [Related]
9. The evidence for the safety of thiomersal in newborn and infant vaccines.
Clements CJ
Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.
Stajich GV; Lopez GP; Harry SW; Sexson WR
J Pediatr; 2000 May; 136(5):679-81. PubMed ID: 10802503
[TBL] [Abstract][Full Text] [Related]
11. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
Dórea JG; Marques RC; Brandão KG
Am J Perinatol; 2009 Aug; 26(7):523-7. PubMed ID: 19283656
[TBL] [Abstract][Full Text] [Related]
12. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):94-7. PubMed ID: 11263794
[TBL] [Abstract][Full Text] [Related]
13. Comparison of organic and inorganic mercury distribution in suckling rat.
Orct T; Blanusa M; Lazarus M; Varnai VM; Kostial K
J Appl Toxicol; 2006; 26(6):536-9. PubMed ID: 17080402
[TBL] [Abstract][Full Text] [Related]
14. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
15. Identification and distribution of mercury species in rat tissues following administration of thimerosal or methylmercury.
Rodrigues JL; Serpeloni JM; Batista BL; Souza SS; Barbosa F
Arch Toxicol; 2010 Nov; 84(11):891-6. PubMed ID: 20386881
[TBL] [Abstract][Full Text] [Related]
16. Speciation of methyl- and ethyl-mercury in hair of breastfed infants acutely exposed to thimerosal-containing vaccines.
Dórea JG; Bezerra VL; Fajon V; Horvat M
Clin Chim Acta; 2011 Aug; 412(17-18):1563-6. PubMed ID: 21575620
[TBL] [Abstract][Full Text] [Related]
17. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
18. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
Geier DA; Geier MR
J Toxicol Environ Health A; 2006 Aug; 69(15):1481-95. PubMed ID: 16766480
[TBL] [Abstract][Full Text] [Related]
20. Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors.
Dórea JG
Am J Perinatol; 2007 Aug; 24(7):387-400. PubMed ID: 17564957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
